Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)
In 2004, the Department of Health and Human Services recognized obesity as an illness, and in 2013, the American Medical Association did as well
order: 20 grams 1 sold Guangzhou Arahelio Biotechnology Co.,Ltd Manufacturer 2 yrsCN4.9/5.0 15% Reorder rate 254 Interested customers 3/3 Matches all GHK-Cu Essence Copper Peptide Firming Anti-Wrinkle Barrier Repair Hydrating Skin-Plumping $15-15.75 Min
Among patients without diabetes, GLP-1 use was associated with a 34% lower risk of fracture for those with osteopenia and a 38% lower risk for those with osteoporosis
Happy Mammoth is a SheKnows sponsor, however, all products in this article were independently selected by our editors